A Clash of Cholesterol Titans: Statin-Intolerant vs. Statin-Tolerant Patients on PCSK9 Inhibitors in long term follow-up
Anno:
2024
Introduction: Statin intolerance remains a clinical challenge in the management of dyslipidemia. This study aimed to investigate whether patients with statin intolerance, receiving PCSK9 inhibitors, exhibit lipid profile improvement different from those obtained in those without statin intolerance. Methods: In this monocentric outpatient study we enrolled 381 dyslipidemic patients…